A 63-year-old female patient reported blisters on the face, neck, upper, and lower limbs, which exuded and evolved as hypochromias and sclerotic areas one year ago, with no therapeutic response to topical corticosteroid therapy and phototherapy (NBUVB). FIgure 1: A. Diffuse sclerotic hypochromic plaques on the face with alopecia. B. Detail of the dyschromic alterations, exulcerated lesion on the forehead, alopecia of the eyebrows and temporal margins Case for diagnosis. Sclerodermiform manifestations of porphyria cutanea tarda secondary to hepatitis C 481 An Bras Dermatol. 2019;94(4):479-81.
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There was restriction on wrist movement and oral opening. She did not report Raynauld's phenomenon or dysphagia, and nailfold capillaroscopy was normal.
FIgure 4:
Clinical picture, indicating remission after treatment with hydroxychloroquine, photoprotection, and cure of hepatitis C reddish fluorescence in urine exposed to Wood's light ( Figure 3 ).
DISCUSSION
In addition to the different clinical forms of cutaneous scleroderma, sclerodermiform disorders may be secondary to graft versus host disease, drugs, silica exposure, porphyrias, silicone implants, paraneoplastic manifestations, and chronic infections. [1] [2] [3] [4] [5] [6] [7] The authors reported a case of porphyria cutanea tarda (PCT) -or chronic hepatic porphyria, with sclerodermiform lesions, secondary to chronic hepatitis C virus, with significant involvement of photoexposed areas (face and upper limbs). 6 The evolution of PCT with cutaneous sclerodermoid lesions and alopecia is uncommon, and is due to the delay in diagnosis. 8 The diagnosis of PCT is given by clinical, histopathology, and porphyrin analysis. In sclerodermiform lesions, sclerosis of the dermis is caused by an increase in collagen I, and the inflammatory infiltrate has prominent mast cells. In this case, the histopathological examination was not conclusive.
Treatment consists of identifying and suspending the triggering factor, associated with specific therapy: phlebotomy and antimalarials.
Phlebotomy promotes reduction of excess iron stocks, characteristic of porphyrias. In patients with concomitant HCV infection, phlebotomy has an additional benefit since iron reduction improves liver inflammation and response to interferon therapy. In this case, anemia contraindicated phlebotomy.
To minimize hepatotoxicity, antimalarials are used in low doses. These drugs have good results for remission of the cutaneous condition by the increase of hepatic excretion of porphyrins.
Oral antivirals for the treatment of HCV infection are the curative strategy in these situations. 9 In the present case, the use of 
